Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.56 |
| ▸ | KDM6B | O15054 | 1/20 | 0.54 |
| ▸ | KDM5C | P41229 | 1/20 | 0.54 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.54 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.54 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | PAM | P19021 | 2/20 | 0.52 |
| ▸ | CES2 | O00748 | 3/20 | 0.50 |
| ▸ | CES1 | P23141 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | PPARG | P37231 | 4/20 | 0.48 |
| ▸ | PPARD | Q03181 | 4/20 | 0.48 |
| ▸ | PPARA | Q07869 | 4/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5559122 | 1.00 | DGKA (0.57) | DGKADNM1KDM6BKDM5CEGLN1 | |
| SCHEMBL555756 | 1.00 | DGKA (0.57) | DGKADNM1KDM6BKDM5CEGLN1 | |
| SCHEMBL15436584 | 1.00 | DGKA (0.57) | DGKADNM1KDM6BKDM5CEGLN1 | |
| SCHEMBL10788076 | 1.00 | DGKA (0.57) | DGKADNM1KDM6BKDM5CEGLN1 | |
| SCHEMBL1044595 | 1.00 | DGKA (0.57) | DGKADNM1KDM6BKDM5CEGLN1 | |
| SCHEMBL21603062 | 1.00 | DGKA (0.57) | DGKADNM1KDM6BKDM5CEGLN1 | |
| SCHEMBL6239209 | 1.00 | DGKA (0.57) | DGKADNM1KDM6BKDM5CEGLN1 | |
| SCHEMBL1671758 | 1.00 | DGKA (0.57) | DGKADNM1KDM6BKDM5CEGLN1 | |
| SCHEMBL1671856 | 1.00 | DGKA (0.57) | DGKADNM1KDM6BKDM5CEGLN1 | |
| SCHEMBL28052374 | 0.98 | DGKA (0.55) | DGKADNM1KDM6BKDM5CEGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11357792-B2 | Method of administration and treatment | Dyvve Biosciences, Inc. (US) | 2022-06-14 | — | — | US | claimed |
| US-20240226000-A9 | TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS | DYVE BIOSCIENCES, INC. | 2024-07-11 | — | — | US | disclosed |
| US-20240130962-A1 | TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS | DYVE BIOSCIENCES INC (US) | 2024-04-25 | — | — | US | disclosed |
| EP-4349414-A2 | METHODS AND FORMULATIONS FOR TRANSDERMAL ADMINISTRATION | Dyve Biosciences, Inc. (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4324460-A2 | SODIUM BICARBONATE FOR USE IN THE TREATMENT OF GOUT AND RELATED DISORDERS | Dyve Biosciences, Inc. (US) | 2024-02-21 | — | — | EP | disclosed |
| US-20240033284-A1 | METHOD OF ADMINISTRATION AND TREATMENT | DYVE BIOSCIENCES, INC. | 2024-02-01 | — | — | US | disclosed |
| EP-3681479-B1 | SODIUM BICARBONATE FOR USE IN THE TREATMENT OF GOUT AND RELATED DISORDERS | DYVE BIOSCIENCES INC (US) | 2024-01-31 | — | — | EP | disclosed |
| EP-3915542-B1 | FORMULATIONS FOR TRANSDERMAL ADMINISTRATION | DYVE BIOSCIENCES INC (US) | 2023-11-22 | — | — | EP | disclosed |
| EP-4277616-A1 | TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS | Dyve Biosciences, Inc. (US) | 2023-11-22 | — | — | EP | disclosed |
| US-11793830-B2 | Method of administration and treatment | DYVE BIOSCIENCES, INC. (US) | 2023-10-24 | — | — | US | disclosed |
| US-20130005708-A1 | HISTAMINE ANTAGONIST TREATMENT OF INFLAMMATORY SKIN DISORDERS | ALLERGAN, INC. | 2013-01-03 | — | — | US | disclosed |
| US-20120269914-A1 | PLANT EXTRACTS FOR TREATING SKIN DISEASES | EVORIA GMBH (DE) | 2012-10-25 | — | — | US | disclosed |
| EP-2498819-A2 | TOPICAL ETORICOXIB FORMULATION COMPRSING AN EUTECTIC MIXTURE OF PERMEATION ENHANCERS | Nuvo Research Inc. (CA) | 2012-09-19 | — | — | EP | disclosed |
| EP-2485730-A1 | TOPICAL FORMULATION COMPRISING ETORICOXIB AND A ZWITTERIONIC SURFACTANT | Nuvo Research Inc. (CA) | 2012-08-15 | — | — | EP | disclosed |
| EP-2482850-A2 | TOPICAL FORMULATIONS | Nuvo Research Inc. (CA) | 2012-08-08 | — | — | EP | disclosed |
| WO-2011060195-A2 | TOPICAL EUTECTIC FORMULATION | NUVO RESEARCH INC. (CA) | 2011-05-19 | — | — | WO | disclosed |
| WO-2011041609-A2 | TOPICAL FORMULATIONS | NUVO RESEARCH INC. (CA) | 2011-04-07 | — | — | WO | disclosed |
| US-20080319092-A1 | Transdermal Drug Delivery Formulation | NUVO RESEARCH INC. (CA) | 2008-12-25 | — | — | US | disclosed |
| CN-1138591-C | Coated particles and methods of making and using the same | ��������Ƥ�����ƹ�˾ | 2004-02-18 | — | — | CN | disclosed |
| CN-1248177-A | Coated particles, method of making and using | SELECT RELEASE L C (US) | 2000-03-22 | — | — | CN | disclosed |